Revvity (RVTY) Gross Margin (2009 - 2026)
Revvity's (RVTY) quarterly Gross Margin came in at 57.13% in Q3 2026, up 263.0% on a YoY basis from 15.74% in Q3 2025, and up 4.8% quarter-over-quarter from 54.51% in Q2 2026.
Analysis
Revvity (RVTY) Gross Margin (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Gross Margin for 18 consecutive years, with 57.13% the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Gross Margin rose 263.0% year-over-year to 57.13%; the trailing twelve-month figure through Jul 2026 stood at 60.97% (down 124.0% YoY), and the FY2025 full-year result was 60.89%, down 130.0% from the prior year.
- Gross Margin grew to 57.13% in Q3 2026 per RVTY's latest filing, from 54.51% in the prior quarter.
- Across five years, Gross Margin topped out at 81.02% in Q1 2023 and bottomed at 53.6% in Q3 2025.
- Historically, Gross Margin has averaged 60.65% across 5 years, with a median of 56.51% in 2023.
- The sharpest annual moves came in 2022 and 2023: Gross Margin jumped 2125 bps in 2022, then tumbled 524 bps in 2023.
- Over 5 years, Gross Margin stood at 57.18% in 2022, then dropped by 3 bps to 55.54% in 2023, then jumped by 45 bps to 80.6% in 2024, then dropped by 4 bps to 77.22% in 2025, then declined by 26 bps to 57.13% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 57.13%, 54.51%, and 77.22% for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 57.64% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 55.48% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 66.44% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 57.13% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 65.82% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 53.12% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 53.91% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 74.48% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 49.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 57.13% |
| Apr 5, 2026 | 54.51% |
| Dec 28, 2025 | 77.22% |
| Sep 28, 2025 | 53.60% |
| Jun 29, 2025 | 54.50% |
| Mar 30, 2025 | 56.49% |
| Dec 29, 2024 | 80.60% |
| Sep 29, 2024 | 56.26% |
| Jun 30, 2024 | 55.73% |
| Mar 31, 2024 | 54.63% |
| Oct 1, 2023 | 55.54% |
| Jul 2, 2023 | 56.74% |
| Apr 2, 2023 | 56.51% |
| Jan 1, 2023 | 81.02% |
| Oct 2, 2022 | 57.18% |
| Jul 3, 2022 | 61.60% |
| Apr 3, 2022 | 61.75% |
| Oct 3, 2021 | 60.70% |
| Jul 4, 2021 | 40.35% |
| Apr 4, 2021 | 49.16% |